---
title: "Appili Therapeutics to Exhibit at World Vaccine Congress Washington | APLIF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281008511.md"
description: "Appili Therapeutics to Exhibit at World Vaccine Congress Washington | APLIF Stock News"
datetime: "2026-03-30T03:20:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281008511.md)
  - [en](https://longbridge.com/en/news/281008511.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281008511.md)
---

# Appili Therapeutics to Exhibit at World Vaccine Congress Washington | APLIF Stock News

Appili Therapeutics to Exhibit at World Vaccine Congress Washington | APLIF Stock News

### Related Stocks

- [APRI.US](https://longbridge.com/en/quote/APRI.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [<![CDATA[FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment ]]>](https://longbridge.com/en/news/282567251.md)
- [IDEAYA eye cancer drug combo meets main goal of mid-to-late-stage trial](https://longbridge.com/en/news/282524512.md)
- [Replimune Disputes FDA Rejection of Skin Cancer Treatment, Criticizes Review Process](https://longbridge.com/en/news/282393660.md)
- [FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short](https://longbridge.com/en/news/282376421.md)
- [Stock Traders Purchase Large Volume of Put Options on Viridian Therapeutics (NASDAQ:VRDN)](https://longbridge.com/en/news/281778939.md)